Optiver Holding’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-92,638
Closed -$13.9M 2998
2026
Q1
$14.2M Sell
92,638
-58,952
-39% -$9.04M ﹤0.01% 318
2025
Q4
$20.9M Sell
151,590
-8,498
-5% -$1.11M 0.01% 249
2025
Q3
$20.5M Sell
160,088
-355,085
-69% -$43.3M 0.01% 219
2025
Q2
$62.3M Buy
515,173
+473,508
+1,136% +$53.4M 0.03% 96
2025
Q1
$4.64M Sell
41,665
-30,763
-42% -$3.28M ﹤0.01% 214
2024
Q4
$7.05M Buy
+72,428
New +$7.72M ﹤0.01% 221
2024
Q3
Sell
-219,044
Closed -$24.9M 1051
2024
Q2
$23.3M Buy
219,044
+8,766
+4% +$880K 0.01% 199
2024
Q1
$20.3M Sell
210,278
-271,899
-56% -$27.9M 0.01% 224
2023
Q4
$48.7M Buy
482,177
+302,390
+168% +$29.2M 0.03% 155
2023
Q3
$18.3M Buy
+179,787
New +$18.2M 0.01% 236
2023
Q2
Sell
-92,697
Closed -$9.27M 554
2023
Q1
$8.53M Sell
92,697
-298,790
-76% -$26.1M 0.01% 293
2022
Q4
$35.5M Buy
391,487
+207,944
+113% +$17.5M 0.04% 159
2022
Q3
$14M Buy
183,543
+34,811
+23% +$2.89M 0.01% 167
2022
Q2
$12.6M Buy
+148,732
New +$13M 0.01% 148
2022
Q1
Sell
-339,452
Closed -$29.4M 766
2021
Q4
$28.1M Buy
339,452
+55,065
+19% +$4.57M 0.02% 117
2021
Q3
$23.3M Buy
284,387
+272,095
+2,214% +$24.5M 0.02% 103
2021
Q2
$1.12M Sell
12,292
-468,320
-97% -$41.7M ﹤0.01% 186
2021
Q1
$41.1M Buy
+480,612
New +$43.1M 0.07% 47

Other funds holding NVS

Optiver Holding's NVS Position: Q2 2026 in Review

Optiver Holding sold out of Novartis (NVS) in Q2 2026, closing a stake of 92,638 shares — an estimated $13.9M sold.

Optiver Holding first reported a position in NVS in Q1 2021 and held it in 18 quarters. The position peaked at $62.3M in Q2 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Optiver Holding reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 92,638 Novartis shares in Q2 2026, an estimated $13.9M.
  • Optiver Holding first reported a position in Novartis in Q1 2021 and held it in 18 quarters.
  • Optiver Holding's Novartis position peaked at $62.3M in Q2 2025.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.